QC CARDIOVASCULAR SYSTEM
QC02 ANTIHYPERTENSIVES
QC02A ANTIADRENERGIC AGENTS, CENTRALLY ACTING
QC02AB Methyldopa
QC02AB01 methyldopa (levorotatory)
QC02AB02 methyldopa (racemic)
Last updated: 2024-01-17
Postal address:
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer
Norwegian Institute of Public Health
WHO Collaborating Centre for Drug Statistics Methodology
Postboks 222 Skøyen
0213 Oslo
Norway
Visiting/delivery address:
Myrens verksted 6H
0473 Oslo
Norway
Tel: +47 21 07 81 60
E-mail:
Copyright/Disclaimer